Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-016945
Filing Date
2019-06-13
Accepted
2019-06-13 20:42:36
Documents
2
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1532
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4795
  Complete submission text file 0000899243-19-016945.txt   7659
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address
High Katherine A (Reporting) CIK: 0001631248 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 19897428

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)